Polypharmacy in elderly patients.

By Emily R Hajjar, A. Cafiero, J. Hanlon. The American Journal of Geriatric Pharmacotherapy, 2007

1,262 citations recorded by the source corpus.

Subfields: Family Practice, Geriatrics and Gerontology, Toxicology

View Paper: https://www.semanticscholar.org/paper/e9ed832d0fc2f703d958700be70e521c88406040

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Terri R Fried
2. J. O'leary
3. Robert L. Maher
4. V. Towle
5. M. K. Goldstein
6. M. Trentalange
7. Deanna K. Martin
8. J. Hanlon

Citations in the corpus

• Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review (2014, positive): “Several prior reviews of polypharmacy focused on the epidemiology of and interventions to reduce polypharmacy rather than on outcomes.(6,7) One review examining outcomes associated with polypharmacy used the key words “polypharmacy” or “multiple medications” as identifiers of studies examining the u”
• Clinical consequences of polypharmacy in elderly (2014, background): “The goal was to update a previous article on this topic written by the authors and published in 2007 [3].”